(Q36506410)

14 August 2017

Long term omeprazole therapy for reflux esophagitis:follow-up in serum gastrin levels,EC cell hyperplasia and neoplasia (English)

1 reference

14 August 2017

1 reference

Pankaj Singh

1

1 reference

14 August 2017

Anant Indaram

2

1 reference

14 August 2017

Ronald Greenberg

3

1 reference

14 August 2017

Vernu Visvalingam

4

1 reference

14 August 2017

Simmy Bank

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

6

1 reference

14 August 2017

789-792

1 reference

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

30 September 2017

Safety of lansoprazole.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Is there any acid peptic disease that is refractory to proton pump inhibitors?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Inhibition of gastrin gene expression by somatostatin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

The gastrin hypothesis. Implications for antisecretory drug selection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Effects of carbachol on gastrin and somatostatin release in rat antral tissue culture

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Somatostatin stimulates gastrin mRNA turnover in dog antral mucosa

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Healing and relapse of reflux esophagitis during treatment with ranitidine.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4728264

Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial

21 September 2018

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects

1 reference

12 December 2020

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

1 reference

12 December 2020

Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis

1 reference

12 December 2020

Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V6.I6.789

0 references

1 reference

14 August 2017

1 reference